Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 01 Feb 2021 for 10x Genomics, Inc..
Filing timeline
BuySalePaladin Capital Management, LLC
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Paladin Capital Management, LLC: trading record in brief
All filings by Paladin Capital Management, LLC on record concern 10x Genomics, Inc. We count 5 filings; the first trade dates from 20 February 2020 and the latest from 30 April 2020.
No open-market purchase appears, only 2 sales worth €71.5M. Since January 2021: no purchases and 2 sales on the market.
The record was last updated on 1 February 2021 with a transaction in 10x Genomics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paladin Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
- 619,306 shares0Class A Common StockSEC:0000899243-21-003990:1
- 1,527,241 shares0Class A Common StockSEC:0000899243-21-003990:2
- 568 shares@ US$74.480.1% of flowClass A Common StockSEC:0000899243-21-003990:3
- 1,000,000 shares@ US$78.2599.9% of flowClass A Common StockSEC:0000899243-21-003990:4
- 8,675,167 sharesClass A Common StockSEC:0000899243-21-003990:0
5 of 5 declarations
